In a significant move signalling an intensified congressional inquiry, the House Judiciary Committee, under the leadership of Chairman Jim Jordan, has issued a subpoena to a former high-ranking executive from Pfizer. This decisive action underscores the committee’s commitment to deeper scrutiny into the operations of the pharmaceutical giant, particularly concerning […]